LeafNLP Demos
Back to explore

Report #2890473

Received Mar 23, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Oct 10, 2024
Onset
Mar 5, 2026
Days to onset
511
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.1Y010045—
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.2Z006738—
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.3Z006738—

Symptoms (2)

Extra dose administeredNo adverse event

Symptom narrative

No additional AE; Nurse reported that a patient inadvertently received the third dose of VARIVAX due to lack of vaccination record at the time of the visit. The patient received first dose of VARIVAX (y010045 5/29/2026) on 10/10/2024, second dose (z006738 3/31/20; This spontaneous report was received from Nurse and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 10-Oct-2024, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) powder and solvent for solution for injection, 1st dose (1.00 dosage form) (total) (Batch/Lot Number: Y010045) (Expiration date: 29-May-2026) (Dose Text: 1 dose). On 05-Feb-2026, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) powder and solvent for solution for injection, 2nd dose (1.00 dosage form) (total) (Batch/Lot Number: Z006738) (Expiration date: 31-Mar-2027) (Dose Text: 1 dose). On 05-Mar-2026, the patient inadvertently received the third dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) powder and solvent for solution for injection due to lack of vaccination record at the time of the visit (1.00 dosage form) (total) (Batch/Lot Number: Z006738) (Expiration date: 31-Mar-2027) (Extra dose administered). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported). The suspect vaccine was administered as prophylaxis. The outcome of the events was not provided. The action taken with the suspect products was not applicable.

Other medications

DILUENT MRK